Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers

por Li, Yan-Ruide, Zeng, Samuel, Dunn, Zachary Spencer, Zhou, Yang, Li, Zhe, Yu, Jiaji, Wang, Yu-Chen, Ku, Josh, Cook, Noah, Kramer, Adam, Yang, Lili
Publicado 2022

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

por Li, Yan-Ruide, Zhou, Yang, Kim, Yu Jeong, Zhu, Yanni, Ma, Feiyang, Yu, Jiaji, Wang, Yu-Chen, Chen, Xianhui, Li, Zhe, Zeng, Samuel, Wang, Xi, Lee, Derek, Ku, Josh, Tsao, Tasha, Hardoy, Christian, Huang, Jie, Cheng, Donghui, Montel-Hagen, Amélie, Seet, Christopher S., Crooks, Gay M., Larson, Sarah M., Sasine, Joshua P., Wang, Xiaoyan, Pellegrini, Matteo, Ribas, Antoni, Kohn, Donald B., Witte, Owen, Wang, Pin, Yang, Lili
Publicado 2021